Hinge Health (HNGE) concentration risks

The company's concentration profile is defined by a high-share channel dependency at the aggregate level and several small individual-counterparty exposures within it. Client contracts through partners accounted for 82% of revenue for the year ended December 31, 2025, a high-share dependency on a distribution model routed through health plan and insurance company intermediaries rather than direct employer relationships. This means the company's revenue growth and contract retention are substantially mediated by its standing with a set of large health plan partners, whose own contracting decisions and member engagement strategies directly shape volume. Within that partner channel, three named payers account for a combined but individually small share of revenue: HCSC at 17.5%, Elevance at 13.7%, and Aetna at 10.5% of revenue — each a small individual share by disclosed size. Despite their small individual shares, these three relationships together represent a meaningful portion of the overall revenue base given the high aggregate dependency on the partner channel. A decision by any one of these payers to reduce their commitment, direct members to a competing platform, or renegotiate terms would have a noticeable but not individually catastrophic effect. The overall profile is one of a partner-channel business where concentration is moderate at the named-counterparty level but high when viewed at the channel level. Monitoring health plan partnership renewals and the competitive positioning of the platform within major payer formularies are the primary due-diligence areas.

For the engine’s reasoning on HNGE’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.